HUAIZHONG HEALTH GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.11 USD | -85.33% |
|
-.--% | -.--% |
| 2023 | Huaizhong Health Group, Inc. cancelled the acquisition of Sannong Youxuan Limited. | CI |
| 2023 | Huaizhong Health Group, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023 | CI |
Valuation
| Fiscal Period: October | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 0.005632 | 0.001534 | 1.45 | 8.828 | 40.03 | 31.83 |
| Enterprise Value (EV) 1 | 0.007014 | 0.001534 | 1.46 | 8.837 | 40.07 | 31.9 |
| P/E ratio | - | -175 x | -6.86 x | -80.3 x | -1,299 x | -1,092 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.14 x | 0.07 x | - | - | - | - |
| EV / Revenue | 0.17 x | 0.07 x | - | - | - | - |
| EV / EBITDA | - | - | -1,16,26,419 x | - | - | - |
| EV / FCF | -9.89 x | - | - | - | - | - |
| FCF Yield | -10.1% | - | - | - | - | - |
| Price to Book | - | - | -68.7 x | -454 x | -796 x | -401 x |
| Nbr of stocks (in thousands) | 0.35 | 0.35 | 518 | 31,518 | 31,518 | 31,518 |
| Reference price 2 | 16.00 | 4.360 | 2.800 | 0.2801 | 1.270 | 1.010 |
| Announcement Date | 13/02/18 | 06/08/19 | 09/01/20 | 22/03/21 | 26/01/22 | 27/03/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: October | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.0405 | 0.0206 | - | - | - | - |
| EBITDA | - | - | -0.1256 | - | - | - |
| EBIT 1 | -0.001135 | 0.000573 | -0.1261 | -0.036 | -0.0308 | -0.0292 |
| Operating Margin | -2.8% | 2.79% | - | - | - | - |
| Earnings before Tax (EBT) 1 | -0.001134 | 0.000575 | -0.1261 | -0.0365 | -0.0308 | -0.0292 |
| Net income 1 | -0.001134 | -0.006368 | -0.1261 | -0.0365 | -0.0308 | -0.0292 |
| Net margin | -2.8% | -30.98% | - | - | - | - |
| EPS | - | -0.0249 | -0.4082 | -0.003489 | -0.000978 | -0.000925 |
| Free Cash Flow 1 | -0.000709 | - | - | - | - | - |
| FCF margin | -1.75% | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 13/02/18 | 06/08/19 | 09/01/20 | 22/03/21 | 26/01/22 | 27/03/23 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: October | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0 | - | 0.01 | 0.01 | 0.04 | 0.07 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | -0.0793 x | - | - | - |
| Free Cash Flow 1 | -0 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | -5.9% | 18.1% | 1,195% | 180% | 88.4% | 45% |
| ROA (Net income/ Total Assets) | -3.44% | - | - | - | - | - |
| Assets 1 | 0.033 | - | - | - | - | - |
| Book Value Per Share | - | - | -0.0400 | -0 | -0 | -0 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 13/02/18 | 06/08/19 | 09/01/20 | 22/03/21 | 26/01/22 | 27/03/23 |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 3.47M | |
| +152.51% | 6.04B | |
| +2.19% | 982M | |
| +41.91% | 872M | |
| +30.42% | 853M | |
| +1.82% | 664M | |
| +5.03% | 620M | |
| -.--% | 600M | |
| +4.44% | 503M | |
| -.--% | 500M |
- Stock Market
- Equities
- ADAD Stock
- Financials Huaizhong Health Group, Inc.